Robin Haralson loves to sing and is an alto in her school’s chorus. A talented student, she regularly receives A’s and B’s. Polite and kind, she answers adults with a “yes, ma’am” or a “no, sir,” like she learned from her parents. Robin seems like an average teenager—excited about summer, when she’ll be able to swim, one of her favorite activities.
But Robin is not your typical teenager. She is a survivor.
When she was 6, Robin was diagnosed with Ewing’s sarcoma, a rare and difficult-to-treat bone cancer. Her parents, Laurie and Rob, were shocked and devastated. Robin received chemotherapy and radiation at the Aflac Cancer Center and Blood Disorders Center of Children’s Healthcare of Atlanta, which treats more than 400 newly diagnosed cancer patients each year.
The treatment was a success, and Robin was in remission for more than a year when the Haralsons were dealt another blow. Robin was diagnosed with acute myelogenous leukemia (AML), a type of cancer that affects white blood cells, and sometimes develops after chemotherapy. She later underwent a successful blood and marrow transplant (BMT), which restored Robin’s damaged blood stem cells.
Today, Robin is cancer-free and regularly participates in the Aflac Cancer Center Cancer Survivor Program. In the fall, Robin will start a new chapter in her life—high school. And this survivor couldn’t be more excited about the chance to make new memories for years to come.